drugset / Trial / NCT04361630
Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Gingival Recession Defects
NaSingle-groupOpen-labelPrevention
Summary
This study was a single-arm trial to obtain preliminary data on the efficacy of collagen membranes impregnated with recombinant human fibroblast growth factor (rhFGF-2) in the treatment of Miller's class I and class II gingival recessions.
Timeline
- Start
- 2019-05-01
- Primary completion
- 2019-11-01
- Completion
- 2019-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FGF-2 | Protein / enzyme biologic | 10 ng/ml | — |